Open Access Research Article
PROTECTION OF FARMERS RIGHTS, PLANT VARIETIES IN INDIA AND ITS IMPACT WITH REFERENCE TO THE GENETICALLY MODIFIED PLANTS: A LEGAL ANALYSIS
Published Paper
Article Details
PROTECTION
OF FARMERS RIGHTS, PLANT VARIETIES IN INDIA AND ITS IMPACT WITH REFERENCE TO
THE GENETICALLY MODIFIED PLANTS: A LEGAL ANALYSIS
AUTHORED
BY - BHAGIRATHI H &
KAVYASHREE AP
India, like many countries, follows
the sui generis legislation to protect the new plant varieties. In India, The
Protection of Plant Varieties and Farmers' Rights (PPVFR) Act, 2001 formally
grants rights to farmers. As technology advances in agriculture, genetically
modified plants have become prevalent. The status of patentability and the
protection of genetically modified plants is currently uncertain in India. This
research article delves into the technology of genetically modified plants and
the protections given to plants, seed varieties and farmer rights under the
PPVFR act by also analysing the impact on them because of the genetically
modified plants honing in on the pivotal issue of seed reuse by the farmers.
The distinctions between the Protection of Plant Varieties and Farmers' Rights
Act (PPVFR) and the Patent Law, spotlighting their divergent features as the
crux of the matter of whether GM plants can be patented is analysed. The
interpretation of section 3(j) of the patents act and its questionable
inclusion of transgenic plants with contemporary cases are dealt in the
article. Drawing parallels with the (EU) Biotech directive and other
international norms, this article discerns the position of GM crops and their
patentability in the Indian context by underscoring the intricate tapestry of
ethical, economic, and environmental considerations,
painting a roadmap for a balanced biotechnological future.
Keywords
Farmer’s rights, Plant varieties,
Genetically Modified Crops, Patentability, Intellectual Property,
Biotechnology.
Introduction
The first nation to recognise the
rights of farmers in plant conservation was India. The Indian experience offers
crucial lessons in realizing Farmers' Rights, given its noteworthy aspects.
These include India's pioneering work in establishing a legal foundation for
Farmers' Rights, its substantial contributions to international discussions on
this topic, and the complex agricultural landscape within India where the
implementation of Farmers' Rights is being actively pursued. Under the TRIPS
Agreement, member countries have the discretion to select the legal framework
for plant varieties and seeds, with the option to choose either a sui generis
law, a patent law, or a combination of both[1].
India has elected to implement a sui generis law, specifically the Protection
of Plant Varieties and Farmers' Rights Act of 2001, to govern this aspect of
intellectual property rights. This legislation aligns not only with the 1978
International Union for the Protection of New Varieties of Plants (UPOV)
agreement but also includes robust provisions safeguarding the interests of
public sector breeding institutions and farmers drawing strong significance
from UPOV. Agriculture is an important
aspect to India. A rapidly increasing population in India has led to poverty
and food shortages. According to the
Global Food security and Nutrition Report, 2019 the target to achieve zero
hunger by 2030 is difficult at the current pace [2]despite
in India where more than 55% of Indian depend on agriculture for their
livelihood.[3] India, a
rapidly progressing nation grappling with a burgeoning population, must prioritize
the adoption of sustainable technologies like genetically modified (GM) crops
engineered to endure drought, enhance nutrient utilization (particularly
nitrogen), and withstand high temperatures. [4]There
exists a widespread global acceptance and consumption of foods derived from GM
crops. As per the 2020 report from the International Service for the
Acquisition of Agri-Biotech Applications, GM crops are embraced by 72 countries
worldwide, either for human consumption, animal feed, or for commercial
cultivation.[5] Despite
numerous extensive studies conducted over five decades in Western countries and
India, specifically focusing on biosafety, environmental safety, and
biodiversity, opponents of GM crop cultivation frequently choose to overlook
these findings. In India, The "Guidelines for Research in Transgenic
Plants, 1998" serve as a framework and regulatory framework for conducting
research involving genetically modified (GM) plants with a focus on addressing
issues related to biosafety, environmental protection, and risk assessment. The
adoption of GM crops and the approval of it has been increasing in the recent
times and may increase further in the coming years. The growing adoption of GM
crops by breeders and farmers could potentially pose certain drawbacks that may
impact farmers' rights under the PPVFR Act. The lack of clarity regarding the
plant protection status of GM crops might open avenues for misuse by
corporations and private breeders, thereby potentially encroaching upon
farmers' rights. This research article goes deeper into examining the patent
eligibility of GM crops and how it influences the rights of farmers in India.
It also explores whether this eligibility could be integrated within the
framework of the PPVFR Act, and it delves into the significant distinctions
between these legislations thereby also analyzing the perspectives of
international treaties and conventions.
The
Technology behind the creation of genetically modified plants
A transgenic plant is considered a
genetically modified organism (GMO), signifying that genes from either an
unrelated plant or a microorganism have been deliberately introduced into a
plant of interest through artificial means, typically utilizing recombinant DNA
(rDNA) technology. Genetically modified organisms (GMOs) developed through
recombinant DNA technology distinguish themselves from traditional breeding
techniques by avoiding the wholesale blending of genomes between different
plant species. Instead, GMOs meticulously and selectively transfer specific DNA
segments from one organism, which contains sought-after genetic material
capable of bestowing desired traits, to the recipient organism using
sophisticated tissue culture methods. To create a transgenic crop, there are
five key steps: DNA extraction, gene cloning, designing the gene for plant use,
transformation, and plant breeding. Understanding DNA is crucial because it
stores genetic information and contains genes that encode specific proteins.
Genes have three parts: a promoter region (to start gene expression), a
termination sequence (to end it), and the coding region (the gene itself).
Genes produce proteins that influence an organism's traits.[6]
Transgenics involves inserting genes
from one organism into another, but we need to identify and sequence the
specific genes responsible for desired traits like yield or pest resistance.
Once identified, we clone these genes using bacterial plasmids, creating many
identical copies. Next, we introduce the cloned gene into the target plant's
nucleus. Two common methods are the "Gene Gun," which shoots
DNA-coated micro-particles into cells, and the Agrobacterium method, using a
bacteria that naturally transfers its DNA to plant cells. In simpler terms, to
make genetically modified crops, we first find and copy the genes we want.
Then, we shoot these genes into plant cells using a "Gene Gun" or use
a bacteria called Agrobacterium to deliver them. This helps us create crops
with specific desirable traits.
Protection
of plant varieties and farmers rights under
the PVPFR
Act
Plant variety protection
A “variety” under The PPVFR Act, 2001
is defined as a subgroup within a broader category of plants that can be
distinguished by factors such as their growth, yield, appearance, fruit, seeds,
or other defining characteristics[7].
The PPVFR Act, 2001 also defines essentially derived varieties, extant variety
and a farmer’s variety. For the protection of plant varieties, section 13 of
the PPVFR ACT, 2001 establishes the "National Register of Plant
Varieties," recording registered plant varieties, breeders' information,
rights, variety names, reproductive details, and key characteristics. An
authority, supervised by the Central Government, will manage this Register and
the Copies will be maintained at branch offices as per Central Government
directives published in the Official Gazette. Section 15 outlines the key
criteria for registering new plant varieties which are novelty,
distinctiveness, uniformity, and stability. Existing varieties can be
registered if they meet distinctiveness, uniformity, and stability criteria
specified in regulations. Variety names must identify without misleading, be
non-offensive, and not prohibited. Geographical names are allowed if deemed
honest by the registrar. These criteria ensure unique and consistent registered
plant varieties.
Farmer’s rights protection:
Chapter VI of the Act deals with the
farmer’s rights. [8]If a
farmer develops a new plant variety, they have the same rights for registration
and protection as a breeder under this Act. Farmers involved in conserving and
improving genetic resources of certain plants can receive recognition and
rewards from the Gene Fund, but only if the material they've preserved has been
used in registered varieties under this Act. Farmers can also continue to save,
use, replant, share, or sell their farm produce, including seeds of protected
varieties, just as they did before this Act came into effect. The farmers
cannot sell branded seeds of protected varieties. The major aspect of ambiguity
of reselling GM crops affects the farmers rights under this act. Certainly,
here are the key points summarized. Similarly, a farmer who unknowingly
infringes on a right established under this Act will not be considered in
violation of that right. When an essentially derived variety is created from a
farmers' variety, the breeder of that farmers' variety cannot authorize it
without the consent of the farmers or farmer communities who contributed to the
preservation or development of the variety. Another major right is exemption
from Fees. Farmers, farmer groups, or village communities are not required to
pay any fees in proceedings before the Authority, Registrar, Tribunal, or High
Court related to this Act or its rules.
Patentability
of GM crops in India
Section 3 of the Patents Act outlines
what cannot be considered as inventions and, therefore, are excluded from
patentability. Under Section 3(h), methods related to agriculture or
horticulture are not considered inventions and cannot be patented[9].
Previously, Section 3(i) included
plants, but in a 2002 amendment, the term 'or plants' was removed. As a result,
the treatment of plants to make them disease-free or increase their economic
value is no longer excluded under Section 3(i) or any other exclusions listed
in Section 3 of the Patents Act. Further, Section 3(c) of the Patents Act specifically
excludes the patentability of "discoveries" related to naturally
occurring living organisms or inanimate substances.[10]
Section 3(j) of the Patents Act
excludes plants and animals, whether in their entirety or any portion thereof,
from being considered inventions and thus, ineligible for patent protection.
This exclusion encompasses seeds, various plant and animal types, and even
encompasses essentially biological methods for producing or propagating plants
and animals.[11]
Varying Interpretations Regarding the
Scope of "Any Part of a Plant" in Section 3(j) of the Patents Act:
Currently, the Indian Patent Office
does not permit claims that encompass eukaryotic cells containing both plant
and animal cells due to objections raised under Section 3(j) of the Patents
Act. The Indian Patent Office categorizes cells, even those produced through
transgenic methods for recombinant plant cells, as a component of a plant.[12]
Intriguingly, in the case of Monsanto Technology LLC v. Controller General
of Patents, The central question revolved around whether the inserted
Non-Native Nucleic Acid Sequence (NAS) becomes integrated as a component of the
plant or seed. If the answer was yes, it would fall within the jurisdiction of
the Plant Variety Protection (PPV) Act. Conversely, if the answer was no, it
would be governed by the Patents Act.
The Controller of Patents rejected
Monsanto's patent application for a method titled "Creating a transgenic
plant with enhanced heat tolerance," citing non-patentable subject matter
under Section 3(j) of the Patents Act. Monsanto contested this decision before
the Intellectual Property Appellate Board (IPAB). The IPAB agreed with
Monsanto's argument that because the creation of the transgenic variety
involved significant human intervention, it could not be classified as an
"essentially biological process" and, therefore, was not subject to
Section 3(j) of the Patents Act and the single bench of Delhi High Court had
held the same.
In a ruling delivered by a single
judge of the Delhi High Court, the judgment favored the reinstatement of a
license that had been terminated by Monsanto. The defendant's arguments
regarding the validity of the patent were rejected. It was decreed that all
companies, including Nuziveedu, which had subscribed, should be permitted to
utilize the patented technology until the lawsuit was resolved. The royalty
fees were to be paid in accordance with the rates set by the state government.
In a contrasting interpretation of
Section 3(j) of the Patents Act, the Division Bench of the Delhi High Court, in
the case of Nuziveedu v. Monsanto [13]on
April 11, 2018, invalidated Monsanto's patent number 214436. They concluded
that the patent's subject matter was not eligible for patent protection under
Section 3(j) of the Patents Act. However, it's noteworthy that the judgment did
not address whether DNA should be considered a component of a plant or not.
Furthermore, the interpretation and application of Section 3(j) of the Patents
Act in this context remain unclear, particularly in cases involving otherwise
patentable elements like modified DNA molecules used to create DNA constructs
for plant transformation.
Upon the appeal of the case in the
Supreme Court of India, the bench emphasized the obligatory consideration of
Section 64 of the Patents Act, 1970, and Section 9 of the CPC, 1908, prior to
the revocation of a patent. Consequently, the earlier decision made by the
single judge bench was affirmed and upheld.
The interpretation of Section 3(j)
should exclude transgenic crops for several compelling reasons:
i)
GM
Crops don't fit the definition of an "essentially biological process"
because they involve a combination of both biological and non-biological
elements. Creating genetically modified (GM) crops entails a biological aspect
where specific genes are extracted from one organism and incorporated into the
DNA of another, like a plant, to achieve desired traits. This part of the
process is biological since it deals with genetic material and living
organisms.
ii)
The
process of transformation, which entails inserting synthetic DNA constructs
into plants using techniques like Agrobacterium tumefaciens or microprojectile
bombardment, is fundamentally different from traditional breeding methods. It's
a microbiological process rather than an essentially biological one. The Delhi
High Court overlooked this distinction, focusing on conventional breeding
techniques for trait introgression rather than the patented transformation
process. Transformation is a laboratory-based, human-developed method, in
contrast to field-based conventional methods like hybridization or
introgression, which involve crossbreeding and self-pollination. Consequently,
transformation should not be considered within the scope of Section 3(j) of the
Patents Act.
iii)
The
crucial point to emphasize is that the initial transformation process, despite
terminological similarities with terms like hybridization, should not be
categorized as an "essentially biological process" for plant
production. Thus, it should not be subject to Section 3(j) of the Patents Act.
The confusion arises from the use of terms like "transformation" and
"hybridization," but it's essential to differentiate them and
highlight that the initial transformation process is a distinct patentable
subject matter in India. This distinction sets it apart from what is regarded
as an "essentially biological process" for plant production.
If GM crops become patentable, it
could potentially resolve the ambiguity surrounding their intellectual property
rights. However, this also raises questions about the rights of farmers and how
they may conflict with the Plant Varieties and Farmers' Rights (PVPFR) Act.
What is urgently required is a well-coordinated effort to strike a balance
between the rights of farmers and clear guidelines for patenting GM crops under
the Patents Act.
Farmer’s
rights and the clash between PVPFR Act and Patents Act
The Plant Variety Protection and
Farmers' Rights (PVPFR) Act and the Patent Act are two distinct pieces of
legislation that play a crucial role in the realm of intellectual property
rights, particularly as they pertain to agriculture. While both acts involve
the protection of certain plant-related innovations, they differ significantly
in their scope, purpose, and implications for farmers' rights.
The PVPFR
Act
The Plant Variety Protection and
Farmers' Rights (PVPFR) Act is Indian legislation established in 2001. Its
primary purpose is to protect new plant varieties while recognizing and
safeguarding the rights of farmers. [14]Breeders
can obtain exclusive rights to commercialize their plant varieties, but farmers
retain essential rights to save, exchange, and use seeds for their crops. This
act strikes a balance between encouraging innovation in plant breeding and
preserving traditional farming practices, promoting agricultural biodiversity
and farmers' well-being. It's a critical piece of legislation that addresses
the intersection of intellectual property rights and agriculture in India.
The Patent
Act, 1970
The Patent Act is a legal framework
governing intellectual property in many countries, including the United States.
It grants inventors exclusive rights to their inventions, preventing others
from making, using, or selling the patented invention for a set period, typically
20 years. In exchange for this monopoly, inventors must disclose their
inventions to the public. The Act encourages innovation by providing inventors
with the opportunity to profit from their creations and ensures that society
benefits from technological advancements. It plays a pivotal role in fostering
innovation, protecting inventors' rights, and promoting progress across various
industries.
The Clash:
PVPFR vs. Patent Act
As the years have gone by, conflicts
have arisen between the PVPFR Act and the Patent Act, particularly concerning
genetically modified crops. The clash between these two pieces of legislation
has raised questions about the extent to which farmers can exercise their
rights and the power dynamics within the agricultural sector. In one instance,
a corporation developed a genetically modified rice variety that promised
enhanced nutritional content and yield. They obtained a patent for this
invention under the Patent Act, giving them exclusive rights to market and sell
the seeds. However, traditional rice farmers in India, who had been cultivating
their indigenous rice varieties for generations, were alarmed.[15]
Under the PVPFR Act, farmers have the right to continue using their traditional
varieties and even share them with others in their community. However, the
introduction of the patented genetically modified rice created a dilemma.
Farmers who chose to grow the new variety found themselves subject to the
corporation's terms, including restrictions on saving and replanting seeds.
This posed a direct challenge to the farmers' traditional practices and
autonomy. The clash between the two acts reached a tipping point when the
corporation sued several farmers for patent infringement, alleging that they
had saved and replanted seeds from the genetically modified rice without
authorisation. This legal battle exposed the tension between the PVPFR Act's
recognition of farmers' rights and the Patent Act's grant of exclusive rights
to inventors. Farmers, along with advocacy groups and civil society
organisations, rallied to defend their rights under the PVPFR Act. They argued
that while patents are essential for incentivising innovation, they should not
come at the expense of traditional farming practices and the well-being of
rural communities. The case garnered widespread attention, sparking a national
and international debate on the intersection of intellectual property rights,
agriculture, and farmers' rights.
The Impact
on Farmers' Rights
The clash between the PVPFR Act and
the Patent Act has significant implications for farmers' rights. On one hand,
the PVPFR Act recognises and protects the rights of traditional farmers to
save, use, and exchange seeds of protected varieties. This provision safeguards
their centuries-old agricultural practices and ensures food security in rural
communities. However, when genetically modified crops patented under the Patent
Act enter the picture, farmers' rights can be curtailed. The exclusive rights
granted to patent holders can limit farmers' autonomy over their seeds and
force them into contractual agreements with corporations. This often results in
a loss of control over farming practices and dependence on external entities
for seeds and technologies. The clash also highlights the potential for
corporations to misuse patent rights. While patents are intended to reward
innovation, they can sometimes be leveraged to create monopolies and control
access to essential agricultural resources. [16]In
the case of genetically modified crops, the patent holder may dictate the terms
of seed purchase, pricing, and usage, which can be detrimental to small-scale
farmers. Farmers' rights, as enshrined in the PVPFR Act, are essential for
maintaining agricultural biodiversity and ensuring food security. These rights
enable farmers to continue their age-old practices of seed saving, exchange,
and adaptation to local conditions. They also promote the conservation of
traditional crop varieties, which are often better suited to specific
ecosystems and climates. However, it's crucial to strike a balance between
farmers' rights and the need to incentivise innovation in agriculture. While
the PVPFR Act safeguards farmers' interests, the Patent Act encourages research
and development by granting exclusive rights to inventors. The challenge lies
in harmonising these two legislative frameworks to ensure that innovation
benefits farmers and society as a whole without compromising traditional
agricultural practices.
Toward a
Resolution: Balancing Innovation and Farmers' Rights
In the wake of the legal battle and
the public outcry, efforts were made to find a middle ground between the PVPFR
Act and the Patent Act. Stakeholders from the government, agricultural
industry, and civil society engaged in extensive dialogues to address the
concerns raised by traditional farmers while acknowledging the importance of
incentivising innovation. One approach was to promote the coexistence of
traditional and genetically modified crops. Under this model, farmers who wish
to continue cultivating traditional varieties are protected by the PVPFR Act,
while those who choose to adopt genetically modified crops can do so under specific
guidelines that balance their rights with patent holders' interests. This
approach seeks to ensure that farmers are not unduly restricted in their
agricultural practices while also allowing for technological advancement.
Additionally, there were calls for increased transparency and fair licensing
practices within the agricultural industry. Advocates argued that patent
holders should make their genetically modified seeds available to farmers at
reasonable prices, allowing them to access these innovations without facing
exorbitant costs. To facilitate the coexistence of these two legislative
frameworks, mechanisms for resolving disputes between farmers and patent
holders were proposed. These mechanisms aim to protect farmers from unwarranted
legal action while ensuring that patent holders can enforce their rights when
necessary.
The clash between the PVPFR Act and
the Patent Act underscores the complex and evolving relationship between
intellectual property rights, agriculture, and farmers' rights. Balancing the
need to incentivise innovation with the preservation of traditional farming
practices is a formidable challenge that requires ongoing dialogue,
collaboration, and thoughtful policymaking. While the PVPFR Act and the Patent
Act serve distinct purposes, they both have a profound impact on farmers' lives
and livelihoods. The recognition of farmers' rights under the PVPFR Act is a
critical step toward safeguarding traditional agriculture and conserving
genetic resources. Simultaneously, the Patent Act plays a crucial role in
driving innovation and technological advancement in agriculture. As we navigate
this intricate terrain, it is essential to prioritise the interests of
small-scale farmers and traditional farming communities. Farmers should have
the autonomy to choose the crops they cultivate and the seeds they use, whether
they opt for traditional varieties or genetically modified ones. At the same
time, patent holders must act responsibly, ensuring that their innovations
benefit society as a whole and do not create undue hardships for farmers.
Ultimately, the clash between these two acts serves as a reminder that the
intersection of laws and agriculture requires constant vigilance and
adaptation. It calls for a commitment to finding solutions that promote both
innovation and the protection of farmers' rights, thereby ensuring a
sustainable and equitable future for agriculture.
International
norms as to GM Crops
Genetically modified (GM) crops and
food has been a topic of international debate and regulation for decades. The
Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement,
established by the World Trade Organization (WTO), lays down certain
international norms that affect the regulation of GM crops and their trade. [17]In
this discussion, we will explore the EU Biotech Directive, various countries'
laws concerning GM plants, and conclude with suggestions for future directions.
TRIPS and
International Norms
The Trade-Related Aspects of
Intellectual Property Rights, better known as TRIPS, stands as a pivotal
international agreement forged under the banner of the World Trade Organization
(WTO). It represents a concerted effort by the global community to create a
unified framework for the protection and enforcement of intellectual property
rights, a domain that encompasses patents, copyrights, trademarks, and trade
secrets. At its core, TRIPS laid out a
set of minimum standards, essentially a floor beneath which no WTO member could
fall when it came to protecting and enforcing intellectual property rights. [18]The
scope of TRIPS encompassed various facets of intellectual property, but its
most far-reaching impact was undoubtedly in the field of patents. TRIPS
introduced the concept of "national treatment," mandating that WTO
member countries treat foreign intellectual property rights holders with the
same degree of protection as they accord to their own citizens or entities.
Additionally, it established the principle of "most-favored-nation"
(MFN) treatment, requiring that all WTO member countries grant equal treatment
to intellectual property rights holders from other member nations. Beyond
setting these fundamental principles, TRIPS delved into the practical aspects
of enforcing intellectual property rights. It outlined measures and procedures,
both civil and criminal, that countries were obligated to put in place to
ensure adequate enforcement. These measures included everything from judicial
processes to border enforcement mechanisms and remedies for infringements.
While TRIPS itself does not specifically address genetically modified (GM)
crops, its influence on the regulation of such crops is substantial. GM crops
often incorporate patented technologies, and the protection of these
innovations is crucial for the continued development and commercialisation of
GM crops. Through TRIPS, countries are prompted to create a legal framework
that upholds intellectual property rights. Biotechnology companies, invested
heavily in research and development, rely on these protections to safeguard
their GM crop innovations, which often involve novel genetic modifications and
associated technologies. Consequently, TRIPS fosters an environment in which
the investments in GM crop research are shielded, enabling further advancements
in agriculture. TRIPS stands as a cornerstone of international norms governing
intellectual property rights. While it directly addresses a broad spectrum of
intellectual property matters, its indirect influence on the regulation and
protection of genetically modified crops cannot be overstated. TRIPS has
ushered in a new era where intellectual property rights are at the forefront of
international trade, shaping the landscape for innovation, commerce, and the
continued development of cutting-edge technologies like GM crops.
EU Biotech
Directive
The European Union (EU) Biotech
Directive is a pivotal piece of legislation that has profoundly influenced the
regulation of genetically modified organisms (GMOs) and genetically modified
(GM) crops within the EU. This directive, formally known as Directive
2001/18/EC, was adopted in 2001 and represents the EU's comprehensive response
to the challenges posed by the advent of biotechnology in agriculture and
environmental management. At its core, the EU Biotech Directive was designed to
establish a stringent regulatory framework for the release and marketing of
GMOs in the European Union. [19]Its
primary focus was on GM organisms, including GM crops, which were becoming
increasingly prevalent in the global agricultural landscape. One of the central
tenets of the Biotech Directive is its insistence on thorough risk assessments
before any GM organisms or products can be approved for release into the
environment. These risk assessments are scientifically rigorous, evaluating the
potential environmental and human health risks posed by GMOs. Furthermore, the
directive places a strong emphasis on the precautionary principle, which means
that, in cases of scientific uncertainty, decisions should err on the side of
caution and prioritise environmental and public safety. The directive also
introduced stringent labelling and traceability requirements. Any product,
including food and feed, containing more than 0.9% of GM ingredients must be
labeled as such. This transparency in labelling ensures that consumers are
aware of the presence of GM components in the products they purchase.
Key aspects of the EU Biotech
Directive include:
1.
Environmental
Risk Assessments: Before a GM crop can be approved, it must undergo a
comprehensive environmental risk assessment. This includes evaluating potential
impacts on non-target organisms, soil, and ecosystems.
2.
Monitoring
and Reporting: The directive requires continuous monitoring of GM crops after
their release to detect any unexpected environmental effects. If such effects
are observed, remedial action can be taken.
3.
Public
Consultation: The directive emphasises the importance of involving the public
in decision-making processes related to GM crops. Public consultations are
conducted to gather input and address concerns.
4.
Safeguard
Measures: If new scientific information emerges indicating potential risks from
a GM crop, the EU has the authority to suspend or withdraw approvals.
5.
Coordination
with Other Legislation: The Biotech Directive is part of a larger framework
that includes regulations on the deliberate release of GMOs into the
environment, the marketing of GM food and feed, and traceability and labelling.
The EU Biotech Directive reflects the
EU's cautious approach to GM crops and their potential impacts on the
environment and human health. It has resulted in a relatively slow and
risk-averse approval process for GM crops within the EU. As a consequence, the
cultivation of GM crops is less common in EU member states compared to other
parts of the world.
GM Crop
Regulations in Other Countries
Genetically modified (GM) crop
regulations vary significantly from one country to another, reflecting diverse
perspectives on agricultural biotechnology, food safety, and environmental
protection. Here, we delve into the GM crop regulations in several countries,
highlighting their approaches and key features.[20][21]
1. United States: The United States has long been a
proponent of GM crops and has one of the most permissive regulatory frameworks.
GM crops undergo a rigorous safety assessment by three federal agencies: the
United States Department of Agriculture (USDA), the Environmental Protection
Agency (EPA), and the Food and Drug Administration (FDA). [22]These
assessments primarily focus on environmental impacts, pesticide use, and food
safety, respectively. While the U.S. emphasises science-based evaluations,
critics argue that the regulatory system priorities commercial interests over
public health and environmental concerns. Moreover, labelling of GM foods is
not mandatory, although many products do carry voluntary labels.
2. China: China is a major player in GM crop
production and has established its regulatory framework. The Ministry of
Agriculture and Rural Affairs (MARA) oversees GM crop approvals and conducts
safety assessments. China has embraced GM crops to increase agricultural
productivity and has developed its GM varieties, such as insect-resistant
cotton and herbicide-tolerant soybeans. However, China also faces challenges
related to unauthorised GM crops and ensuring adherence to regulations.
3. Brazil: Brazil has become a significant
producer of GM crops, particularly soybeans and maize. Its regulatory body, the
National Biosafety Technical Commission (CTNBio), conducts safety assessments
before commercialisation. Brazil's embrace of GM crops has driven agricultural
growth but has also raised concerns about deforestation and pesticide use. The
country's regulatory framework focuses on safety and technology adoption to
enhance agricultural productivity.
Conclusion
It's worth noting that biotechnology
companies are typically the ones with the resources and expertise to develop GM
crops in laboratories, while small agricultural companies and individual
farmers lack such capabilities. Therefore, finding a solution that protects the
interests of both parties and creates a win-win scenario is of utmost
importance at this juncture.
[6] Jamiepighin. (2003). Transgenic
crops: How genetics is providing new ways to envision agriculture. The Science
Creative Quarterly. 08.20.2006, Textbook, http://www.scq.ubc.ca/
transgenic-crops-how-genetics-is-providing-new-ways-to-envision-agriculture/
[7] THE PROTECTION OF PLANT VARIETIES
AND FARMERS’ RIGHTS ACT, 2001, § 2, Gazette of India Extraordinary, Part II,
sec. 3(ii) ( 19th October, 2006)
[11] Section 3(j) of the Patents Act
reads as: “3. What are not inventions.—The following are not inventions within
the meaning of this Act,—….(j) plants and animals in whole or any part thereof
other than micro organisms but including seeds, varieties and species and
essentially biological processes for production or propagation of plants and
animals;…..”
[12] Malathi Lakshmikumaran, Genetically
Modified Plants: The IP and Regulatory Concerns in India, ,
Innovation, Economic Development, and Intellectual Property in India and China(
e book) , pg 368, ISBN
978-981-13-8102-7.
[13] Monsanto Technology
LLC and Ors. vs. Nuziveedu Seeds Ltd. and Ors. (08.01.2019
SC) (MANU/SC/0027/2019)
Article Information
PROTECTION OF FARMERS RIGHTS, PLANT VARIETIES IN INDIA AND ITS IMPACT WITH REFERENCE TO THE GENETICALLY MODIFIED PLANTS: A LEGAL ANALYSIS
Authors: BHAGIRATHI H, KAVYASHREE AP
- Journal IJLRA
- ISSN 2582-6433
- Published 2023/11/24
- Issue 7
About Journal
International Journal for Legal Research and Analysis
- Abbreviation IJLRA
- ISSN 2582-6433
- Access Open Access
- License CC 4.0
All research articles published in International Journal for Legal Research and Analysis are open access and available to read, download and share, subject to proper citation of the original work.
Disclaimer: The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of International Journal for Legal Research and Analysis.